Trial · NCT03179631
Adverse events224
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 224
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gastroenteritis | Infections and infestations | DB Period: Ataluren | 0 | 184 | 0 |
| other | Gastroenteritis | Infections and infestations | DB Period: Placebo | 0 | 176 | 0 |
| other | Gastroenteritis | Infections and infestations | Ataluren /Ataluren | 14 | 184 | 17 |
| other | Gastroenteritis | Infections and infestations | Ataluren/Placebo | 2 | 172 | 2 |
| other | Back pain | Musculoskeletal and connective tissue disorders | DB Period: Ataluren | 0 | 184 | 0 |
| other | Back pain | Musculoskeletal and connective tissue disorders | DB Period: Placebo | 0 | 176 | 0 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Ataluren /Ataluren | 11 | 184 | 13 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Ataluren/Placebo | 6 | 172 | 8 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | DB Period: Ataluren | 0 | 184 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | DB Period: Placebo | 0 | 176 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Ataluren /Ataluren | 12 | 184 | 17 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Ataluren/Placebo | 3 | 172 | 4 |
| serious | Myocarditis | Cardiac disorders | DB Period: Ataluren | 0 | 184 | 0 |
| serious | Myocarditis | Cardiac disorders | DB Period: Placebo | 1 | 176 | 1 |
| serious | Myocarditis | Cardiac disorders | Ataluren /Ataluren | 0 | 184 | 0 |
| serious | Myocarditis | Cardiac disorders | Ataluren/Placebo | 0 | 172 | 0 |
| serious | Sebaceous naevus | Congenital, familial and genetic disorders | DB Period: Ataluren | 1 | 184 | 1 |
| serious | Sebaceous naevus | Congenital, familial and genetic disorders | DB Period: Placebo | 0 | 176 | 0 |
| serious | Sebaceous naevus | Congenital, familial and genetic disorders | Ataluren /Ataluren | 1 | 184 | 1 |
| serious | Sebaceous naevus | Congenital, familial and genetic disorders | Ataluren/Placebo | 0 | 172 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03179631/events?page=4